202 related articles for article (PubMed ID: 12387034)
21. Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea.
Hirose T; Miyashita Y; Takagi M; Sumitani S; Kouhara H; Kasayama S
Diabetes Res Clin Pract; 2001 Oct; 54(1):9-15. PubMed ID: 11532325
[TBL] [Abstract][Full Text] [Related]
22. Rapid improvement of serum 1,5-anhydroglucitol concentrations after administration of alpha-glucosidase inhibitor.
Yoshioka K; Azukari K; Yoshida T; Kondo M
Diabetes Care; 1997 Mar; 20(3):462. PubMed ID: 9051408
[No Abstract] [Full Text] [Related]
23. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
24. Effect of an alpha-glucosidase inhibitor combined with sulphonylurea treatment on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Okada S; Ishii K; Tanokuchi S; Hamada H; Ichiki K; Ota Z
J Int Med Res; 1995; 23(4):279-83. PubMed ID: 7589771
[TBL] [Abstract][Full Text] [Related]
25. [Oral hypoglycemic agents--overview].
Sakamoto N; Uno T
Nihon Rinsho; 1997 Nov; 55 Suppl():94-8. PubMed ID: 9434450
[No Abstract] [Full Text] [Related]
26. [Glimepiride].
Nakamura N
Nihon Rinsho; 2002 Sep; 60 Suppl 9():351-6. PubMed ID: 12387017
[No Abstract] [Full Text] [Related]
27. The efficacy of voglibose on glycemic excursions in non-insulin-treated NIDDM patients.
Yoshioka K; Yokoo S; Yoshida T
Diabetes Care; 1998 Jul; 21(7):1206-7. PubMed ID: 9653625
[No Abstract] [Full Text] [Related]
28. [Adverse effects of oral hypoglycemic agents].
Mori Y; Sekihara H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():325-31. PubMed ID: 12387013
[No Abstract] [Full Text] [Related]
29. [Proper selection and practical administration of sulphonylurea agents to diabetics].
Kurahachi H
Nihon Rinsho; 2002 Sep; 60 Suppl 9():346-50. PubMed ID: 12387016
[No Abstract] [Full Text] [Related]
30. Insulin secretion levels necessary for efficacy of an alpha-glucosidase inhibitor on glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
J Int Med Res; 1995; 23(6):497-501. PubMed ID: 8746619
[TBL] [Abstract][Full Text] [Related]
31. Oral antidiabetic agents. The emergence of alpha-glucosidase inhibitors.
Lebovitz HE
Drugs; 1992; 44 Suppl 3():21-8. PubMed ID: 1280574
[TBL] [Abstract][Full Text] [Related]
32. Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients.
Matsumoto K; Yano M; Miyake S; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
Diabetes Care; 1998 Feb; 21(2):256-60. PubMed ID: 9539992
[TBL] [Abstract][Full Text] [Related]
33. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
Ishii J; Inoue I
Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
[No Abstract] [Full Text] [Related]
34. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
35. [Combination therapy with insulin and sulfonylurea].
Takamatsu J
Nihon Rinsho; 1997 Nov; 55 Suppl():255-60. PubMed ID: 9434477
[No Abstract] [Full Text] [Related]
36. [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Rybka J
Vnitr Lek; 2001 May; 47(5):285-90. PubMed ID: 11395869
[TBL] [Abstract][Full Text] [Related]
37. Initiating oral anti diabetic drug: alternatives to metformin.
Kalra S; Gupta Y
J Pak Med Assoc; 2015 Apr; 65(4):440-1. PubMed ID: 25976586
[TBL] [Abstract][Full Text] [Related]
38. Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
Ishida H; Kato S; Nishimura M; Mizuno N; Fujimoto S; Mukai E; Kajikawa M; Yamada Y; Odaka H; Ikeda H; Seino Y
Horm Metab Res; 1998 Nov; 30(11):673-8. PubMed ID: 9918384
[TBL] [Abstract][Full Text] [Related]
39. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
Ravina A; Minuchin O
Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
[No Abstract] [Full Text] [Related]
40. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
Scheen AJ; Lefèbvre PJ
Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
